Apimeds Pharmaceuticals US
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APUS and other ETFs, options, and stocks.About APUS
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS).
APUS Key Statistics
Stock Snapshot
As of today, Apimeds Pharmaceuticals US(APUS) shares are valued at $4.92. The company's market cap stands at 7.53M, with a P/E ratio of -0.17.
During the trading session on 2026-08-05, Apimeds Pharmaceuticals US(APUS) shares reached a daily high of $5.16 and a low of $4.60. At a current price of $4.92, the stock is +7.0% higher than the low and still -4.6% under the high.
Trading activity shows a volume of 16.86K, compared to an average daily volume of 75.55K.
The stock's 52-week range extends from a low of $4.15 to a high of $59.70.
The stock's 52-week range extends from a low of $4.15 to a high of $59.70.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.